PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40122C00181Fund the remaining balance of the — Brigham & Womens Hospital Inc

Brigham & Womens Hospital Inc holds $20.7M across 79 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Jan 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
Brigham & Womens Hospital Inc
Recipient
Jan 29, 2027
PoP end
$3.7M
Obligated
$4.7M
Potential
541714
NAICS
AN11
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40122C00181
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentBrigham & Womens Hospital Inc
CAGE0W3J1
UEIQN6MS4VN7BD1
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11
Place of performanceSILVER SPRING MD
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startSep 21, 2022
PoP end (current)Jan 29, 2027
Obligated$3.7M
Current value$4.7M
Potential value$4.7M

Fund the Remaining Balance of the Contract of $991,150.00 as Referenced Per FAR 52.232-18 is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by Brigham & Womens Hospital Inc. Estimated value $4.7M ($3.7M obligated). Current period of performance ends Jan 29, 2027. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

Fund the remaining balance of the contract of $991,150.00 as referenced per far 52.232-18. Latest action is a modification.

Recompete timing

Public
● Expiring in 104 days

Current PoP ends Jan 29, 2027 (104 days remaining). Agencies typically plan 12–18 months ahead — at 3.4 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 75F40122C00181? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Brigham & Womens Hospital Inc — $20.7M obligated across 79 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($20.7M) · all agencies
Department of Veterans Affairs (VA)$13.0M · 63%Department of Health and Human Services (HHS)$6.9M · 33%National Aeronautics and Space Administration (NASA)$1.5M · 7%Department of Justice (DOJ)$14K · 0%
Open full company profile →

Related awards

Same incumbent
75F40122C00154
DESIGN A TWO-STAGE PROCESS FOR USING RWE TO SUPPORT LABELING EXPANSIONS FOR EFFECTIVENESS …
$2.7M
Jun 27, 2027
36C24126N0716
LUNG TRANSPLANT SERVICES
$3.3M
Jun 30, 2027
36C24E26N0226
BIOINFORMATICS RESEARCH SUPPORT
$838K
Sep 13, 2027
36C24E26N0222
BIOINFORMATICS RESEARCH SUPPORT
$740K
Sep 13, 2027
36C24E26N0224
BIOINFORMATICS RESEARCH SUPPORT
$641K
Sep 13, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40122C00181?

75F40122C00181 (Fund the remaining balance of the) is a Fda Office Of Acq Grant Svcs award with a potential value of $4.7M, currently held by Brigham & Womens Hospital Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40122C00181?

Fda Office Of Acq Grant Svcs awarded 75F40122C00181 to Brigham & Womens Hospital Inc (potential $4.7M).

Who is the incumbent on 75F40122C00181?

Brigham & Womens Hospital Inc is the incumbent with $20.7M across 79 related awards in SCOUT’s public footprint. The current period of performance ends Jan 29, 2027.

When does Brigham & Womens Hospital Inc’s 75F40122C00181 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40122C00181? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40122C00181